Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia

Annals of Hematology

Volumn 93, Issue 8, 2014, Pages 1441-1442

  Chen, Yi Yang ^a   Huang, Cih En ^a   Chou, Hui Ju ^a   Tsai, Pei Shan ^a   Lu, Chang Hsien ^a,b   Chen, Miao Fen ^a,b   Lee, Kuan Der ^a,b   Chen, Ping Tsung ^a,b   Lung, Jrhau ^a   Chen, Chih Cheng ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; DNA METHYLTRANSFERASE 3A;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER INFILTRATION; CANCER PATIENT; CANCER RISK; CASE REPORT; CENTRAL NERVOUS SYSTEM LEUKEMIA; CEREBROSPINAL FLUID CYTOLOGY; COGNITIVE DEFECT; CONTROLLED STUDY; DNMTT3A GENE; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LEUKEMIA CELL; LEUKEMIA REMISSION; LEUKEMOGENESIS; MIDDLE AGED; MOLECULAR CLONING; MOLECULAR PATHOLOGY; NPM1 GENE; PRIORITY JOURNAL; SYSTEMIC THERAPY; TUMOR GENE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN; CLONE CELLS; CYTARABINE; DAUNORUBICIN; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKEMIC INFILTRATION; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PROGNOSIS; RISK;

EID: 84904663897     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1985-9     Document Type: Letter

References (8)

1. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD et al (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481(7382):506-510
2. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J, Welch J et al (2010) DNMT3A mutations in acute myeloid leukemia. N Engl J Med 363(25):2424-2433
3. Marcucci G, Metzeler KH, Schwind S, Becker H, Maharry K, Mrozek K, Radmacher MD, Kohlschmidt J, Nicolet D, Whitman SP et al (2012) Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acutemyeloid leukemia. J Clin Oncol 30(7):742-750
4. Renneville A, Boissel N, Nibourel O, Berthon C, Helevaut N, Gardin C, Cayuela JM, Hayette S, Reman O, Contentin N et al (2012) Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Leukemia 26(6):1247-1254
5. Ribeiro AF, Pratcorona M, Erpelinck-Verschueren C, Rockova V, Sanders M, Abbas S, Figueroa ME, Zeilemaker A, Melnick A, Lowenberg B et al (2012) Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. Blood 119(24):5824-5831
6. Gaidzik VI, Schlenk RF, Paschka P, Stolzle A, Spath D, Kuendgen A, von Lilienfeld-Toal M, BruggerW, Derigs HG, Kremers S et al (2013) Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG). Blood 2013
7. Abdel-Wahab O, Levine RL (2013) Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood 121(18):3563-3572
8. Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O et al (2012) Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 366(12):1079-1089